Synthesis and anti-HCV evaluation of 4'(α)-ethyl and 2'(β)-methyl-carbodine analogues

Nucleosides, Nucleotides and Nucleic Acids

Volumn 28, Issue 9, 2009, Pages 809-820

  Li, Hua ^a   Yoo, Jin Cheol ^a   Hong, Joon Hee ^a  

^a Chosun University   (South Korea)

Author keywords

Anti HCV agent; Branched carbocyclic nucleoside; Carbodine

Indexed keywords

CARBODINE; CARBODINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DESILYLATION; DIHYDROXYLATION; DRUG SYNTHESIS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; RING CLOSING METATHESIS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; CYCLOPENTANES; CYTIDINE; HEPACIVIRUS; HUMANS; MOLECULAR STRUCTURE; NUCLEIC ACID SYNTHESIS INHIBITORS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 75149134703     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770903170294     Document Type: Article

References (36)

1. Szabo, E.; Lotz, G.; Paska, C.; Kiss, A.; Schaff, Z. Viral hepatitis: new data on hepatitis C infection. Pathol. Oncol. Res. 2003, 9, 215-221.
2. Hughes, C.A.; Shafran, S.D. Treatment of hepatitis C in HIV-coinfected patients. Ann. Pharmacother. 2006, 40, 479-489.
3. a) Bera, S.; Malik, L.; Bhat, B.; Carroll, S.S.; MacCoss, M.; Olsen, D.B.; Tomassini, J.E.; Eldrup, A. B. Synthesis and evaluation of optically pure dioxolanes as inhibitors of hepatitis C virus RNA replication. Bioorg. Med. Chem. Lett. 2003, 13, 4455-4458.
4. b) Eldrup, A.B.; Prhavc, M.; Brooks, J.; Bhat, B.; Prakash, T.P.; Song, Q.; Bera, S.; Bhat, N.; Dande, P.; Cook, P.D.; Bennett, C.F.; Carroll, S.S.; Ball, R.G.; Bosserman, M.; Burlein, C.; Colwell, L.F.; Fay, J.F.; Flores, O.A.; Getty, K.; LaFemina, R.L.; Leone, J.; MacCoss, M.; McMasters, D.R.; Tomassini, J.E.; Von Langen, D.; Wolanski, B.; Olsen, D.B. Structure-activity relationship of heterobase-modified 2′ -C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. J. Med. Chem. 2004, 47, 5284-5297 (Pubitemid 39314927)
5. c) Clark, J.L.; Hollecker, L.; Mason, J.C.; Stuyver, L.J.; Tharnish, P.M.; Lostia, S.; McBrayer, T.R.; Schinazi, R.F.; Watanabe, K.A.; Otto, M.J.; Furman, P.A.; Stec, W.J.; Patterson, S.E.; Pankiewicz, K.W. Design, synthesis, and antiviral activity of 2′-deoxy-2′-fluoro-2′-C- methylcytidine, a potent inhibitor of hepatitis C virus replication. J. Med. Chem. 2005, 48, 5504-5508.
6. d) Smith, D.B.;Martin, J.A.; Klumpp, K.; Baker, S.J.; Blomgren, P.A.; Devos, R.; Granycome, C.; Hang, J.; Hobbs, C.J.; Jiang, W.R.; Laxton, C.; Le Pogam, S.; Leveque, V.; Ma, H.; Maile, G.; Merrett, J.H.; Pichota, A.; Sarma, K.; Smith, M.; Swallow, S.; Symons, J.; Vesey, D.; Najera, I.; Cammack, N. Design, synthesis and antiviral properties of 4′-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479. Bioorg. Med. Chem. Lett. 2007, 17, 2570-2576.
7. El Kouni,M.H. Trends in the design of nucleoside analogues as anti-HIV drugs. Curr. Pharm. Design 2002, 8, 581-593.
8. Eldrup, A.B.; Allerson, C.R.; Bennett, C.F.; Bera, S.; Bhat, B.; Bhat, N.; Bosserman, M.R.; Brooks, J.; Burlein, C.; Carrol, S.S.; Cook, P.D.; Getty, K.L.; MacCross, M.; McMasters, D.R.; Olsen, D.B.; Prakash, T.P.; Prhavc, M.; Song, Q.L.; Tomassini, J.E.; Xia, J. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J. Med. Chem. 2004, 47, 2283-2295.
9. Carrol, S.S.; Tomassini, J.E.; Bosserman, M.; Getty, K.; Stahlhut, M.W.; Eldrup, A.B.; Bhat, B.; Hall, D.; Simcoe, A.L.; LaFemina, R.; Rutkowski, C.A.; Wolanski, B.; Yang, Z.; Migliaccio, G.; De Francesco, R.; Kuo, L.C.; MacCross, M.; Olsen, D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 2003, 278, 11979-11984. (Pubitemid 36800172)
10. Haraguchi, K.; Takeda, S.; Tanaka, H.; Nitanda, T.; Baba, M.; Dutschman, G.E.; Cheng, Y.-C. Synthesis of a highly active new anti-HIV agent 2′,3′-dideoxy-3′-deoxy-4′-ethynythymidine. Bioorg. Med. Chem. Lett. 2003, 13, 3775-3777.
11. Kumamoto, H.; Nakai, T.; Haraguchi, K.; Nakamura, K.T.; Tanaka, H.; Baba, M.; Cheng, Y. -C. Synthesis and anti-human immunodeficiency virus activity of 4′-branched (±)-4′-thiostavudines. J. Med. Chem. 2006, 49, 7861-7867.
12. Boojamra, C.G.; Parrish, J.P.; Sperandio, D.; Gao, Y.; Petrakovsky, O.V.; Lee, S.K.; Markevich, D.Y.; Vela, J.E.; Laflamme, G.; Chen, J.M.; Ray, A.S.; Barron, A.C.; Sparacino, M.L.; Desai, M.C.; Kim, C.U.; Cihlar, T.; Mackman, R.L. Design, synthesis and anti-HIV activity of 4′-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors. Bioorg. Med. Chem. 2009, 17, 1739-1746.
13. a) Smith, D.B.; Kalayanov, G.; Sund, C.; Winqvist, A.; Maltseva, T.; Leveque, V.J.; Rajyaguru, S.; Pogam, S.L.; Najera, I.; Benkestock, K.; Zhou, X.X.; Kaiser, A.C.; Maag, H.; Cammack, N.; Martin, J.A.; Swallow, S.; Johansson, N.G.; Klumpp, K.; Smith, M. The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis c virus replication: the discovery of 4′-azido-2′-deoxy-2′- fluorocytidine and 4′-azido-2′-dideoxy-2′,2′- difluorocytidine. J. Med. Chem. 2009, 52, 219-223.
14. b) Gosselin, G.; Griffe, L.; Meillon, J.-C.; Storer, R. A short synthesis and novel synthesis of carbocyclic nucleosides and 4′-epi-carbocyclic nucleosides from 2-cyclopenten- 1-ones. Tetrahedron 2006, 62, 906-914.
15. c) Meillon, J.C.; Griffe, L.; Storer, R.; Gosselin, G. Rapid access to 2′-branched carbocyclic nucleosides and their 4′-epimers from 2-alkyl-cyclopenten-1-ones. Nucleosides, Nucleotides & Nucleic Acids 2005, 24, 695-699.
16. Liu, L.J.; Yoo, J.C.; Hong, J.H. Efficient synthesis of 4′-cyclopropyl carbovir analogues with use of ring-closing metathesis from glycolate. Nucleosides, Nucleotides & Nucleic Acids, 2008, 27, 1186-1196.
17. a) Qu, B.; Collum, D.B. Mechanism of acylation of lithium phenylacetylide with a Weinreb amide. J. Org. Chem. 2006, 71, 7117-7119.
18. b) Murphy, J.A.; Commeureuc, A.G.; Snaddon, T.N.; McGuire, T.M.; Khan, T.A.; Hisler, K.; Dewis, M.L.; Carling, R. Direct conversion of N-methoxy-N-methylamides (Weinreb amides) to ketones via a nonclassical Wittig reaction. Org. Lett. 2005, 7, 1427-1429.
19. c) De Luca, L.; Giacomelli, G.; Taddei, M. An easy and convenient synthesis of Weinreb amides and hydroxamates.J. Org. Chem. 2001, 66, 2534-2537.
20. a) Lee, J.Y.; Oh, C.H.; Ko, O.H.; Hong, J.H. Synthesis and anti-HCMV activity of novel acyclic nucleosides. Nucleosides, Nucleotides & Nucleic Acids 2002, 25, 709-721.
21. b) Krawczyk, H.; Wasek, K.; Kedzia, J.; Wojciechowski, J.; Wolf, W.M. A general stereoselective method for the synthesis of cyclopropanecarboxylates. A new version of the homologous Horner-Wadsworth-Emmons reaction. Org. Biomol. Chem. 2008, 6, 308-318.
22. a) Ziegler, F.E. The thermal, aliphatic Claisen rearrangement. Chem. Rev. 1988, 88, 1423-1452.
23. b) Ozturk, C.; Aviyente, V.; Houk, K.N. Modeling the stereoselectivity of the Johnson-Claisen rearrangements in the Danishefsky synthesis of gelsemine. J. Org. Chem. 2005, 70, 7028-7034.
24. c) Meza-Aviña, M.E.; Ordoñez, M.; Ferńandez-Zertuche, M.; Rodŕiguez-Fragoso, L.; Reyes-Esparza, J.; de Los Ŕios-Corsino, A.A. Synthesis of some monocyclic analogues of mycophenolic acid via the Johnson ortho ester Claisen rearrangement. Bioorg. Med. Chem. 2005, 13, 6521-6528.
25. d) Feng, J.P.; Shi, Z.F.; Li, Y.; Zhang, J.T.; Qi, X.L.; Chen, J.; Cao, X.P. An improved asymmetric synthesis of malyngamide U and its 2′-epimer. J. Org. Chem. 2008, 73, 6873-6876.
26. a) Furstner, A. Olefin metathesis and beyond. Angewandte Chemie Internal Edition in English 2000, 39, 3012-3043.
27. b) Prunet, J. Recent methods for the synthesis of (E)-alkene units in macrocyclic natural products. Angewandte Chemie Internal Edition in English 2003, 42, 2826-2830.
28. c) Rivkin, A.; Cho, Y.S.; Gabarda, A.E.; Yoshimura, F.; Danishefsky, S.J. Application of ring-closing metathesis reactions in the synthesis of epothilones. J. Nat. Prod. 2004, 67, 139-143.
29. d) Deiter, A.; Martin, S. F. Synthesis of oxygen- and nitrogen-containing heterocycles by ring-closing metathesis. Chem. Rev. 2004, 104, 2199-2238.
30. e) Gaich, T.; Mulzer, J. Recent applications of olefin ring-closing metathesis (RCM) in the synthesis of biologically important alkaloids, terpenoids, polyketides and other secondary metabolites. Curr. Top. Med. Chem. 2005, 5, 1473-1494.
31. a) Doucet, H.; Hierso, J.C. Palladium coupling catalysts for pharmaceutical applications. Curr. Opin. Drug Discov. Develop. 2007, 10, 672-690.
32. Nicolaou K.C.;Bulger P.G.;Sarlah D. Palladiumcatalyzed cross-coupling reactions in total synthesis. Angewandte Chemie [Intl. edition in English]. 2005, 44, 4442-4489.
33. c) Crimmins, M.T.; King, B.W.; Zuercher, W.J.; Choy, A.L. An efficient, general asymmetric aldol/ring-closing metathesis strategy. J. Org. Chem. 2000, 65, 8499-8509.
34. a) Brown, B.; Hegedus, L.S. A novel, one-pot ring expansion of cyclobutanones. synthesis of carbovir and aristeromycin. J. Org. Chem. 2000, 65, 1865-1872.
35. b) Burlina, F.; Favre, A.; Fourrey, J.-L.; Thomas, M. An expeditious route to carbocyclic nucleosides: (?)-aristeromycin and (?)-carbodine. Bioorg. Med. Chem. Lett. 1997, 7, 247-250.
36. Watashi, K.; Hijikata, M.; Hosaka, M.; Yamaji, M.; Shimotohno, K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatol. 2003, 38, 1282-1288.